Cytokine Signaling and Primary Immunodeficiency
Cytokine Signaling and Primary Immunodeficiency
批准号:
8344727
负责人:
John O'Shea
金额:
$19.16万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AllelesAutoimmune DiseasesB-LymphocytesBindingCell Differentiation processCell physiologyCellsClinical ProtocolsCytokine SignalingDefectDevelopmentDiseaseDominant-Negative MutationEnrollmentEpigenetic ProcessFailureGene TargetingGenesGenetic RecombinationGenetic TranscriptionHomeostasisHumanIgEImmuneImmune responseImmunoglobulin Switch RecombinationImmunologic Deficiency SyndromesInflammationInflammatory Bowel DiseasesInflammatory ResponseInterleukin 2 Receptor GammaInterleukin-15Interleukin-2Interleukin-4Interleukin-7Interleukin-9Janus kinaseJob&aposs SyndromeLaboratoriesLymphoidMediatingMemoryMessenger RNAModificationMolecularMusMutationOccupationsPathogenesisPatientsPhosphotransferasesProteinsPsoriasisReceptor ActivationRheumatoid ArthritisRoleSTAT3 geneScientistSerumSevere Combined ImmunodeficiencySystemic Lupus ErythematosusT-LymphocyteTransgenic MiceUnited States National Institutes of HealthWorkbasecell growthchromatin immunoprecipitationcytokinegenome-wideinhibitor/antagonistinsightmouse modelmutantnew technologynew therapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cytokines represent a large number of secreted proteins that regulate cell growth and differentiation. These factors are especially important in regulating immune and inflammatory responses, regulating lymphoid development and differentiation. Cytokines also regulate immune homeostasis, tolerance, and memory. Not surprisingly, cytokines are critical in the pathogenesis of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease and psoriasis. Understanding the molecular basis of cytokine action provides important insights into the pathogenesis of immune-mediated disease and offers new therapeutic targets.
We discovered Jak3, a kinase essential for signaling by cytokines that bind the common gamma chain, gc (IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21). We found that mutation of Jak3 results in a primary immunodeficiency disorder termed severe combined immunodeficiency (SCID). We have a clinical protocol that allows us to evaluate patients with suspected Jak3 deficiency. No new patients were enrolled this year.
Recent work by NIH scientists has revealed that another primary immunodeficiency syndrome, Job's or Hyperimmunoglobulin E syndrome is due to STAT3 mutations. Based on our studies in the mouse, we investigated if mutations of STAT3 in humans are associated with impaired Th17 differentiation. We found this to be the case in patients with Job's syndrome. Mutations of STAT3 underlie hyper-IgE syndrome (HIES), but deciphering STAT3s role in pathogenesis has been hampered by the lethality associated with germline deletion of Stat3. Furthermore, the mechanisms responsible for IgE hyperproduction are unknown. We show that transgenic mice expressing a HIES-Stat3 allele recapitulate aspects of HIES, including elevated serum IgE. Surprisingly, mutant B cells display increased Ig germline transcription and switch recombination upon ex-vivo activation, demonstrating the hyper-IgE defect is B cell intrinsic. Using ChIP- and mRNA-Seq we show that Stat3 directly regulates B cell expression of Id2, an inhibitor of - switching. Ectopic Id2 expression restores normal Ig transcription and recombination, arguing that failure to induce Id2 is an important mechanism underlying the hyper-IgE aspect of this disease
We have also employed new technology to begin to define STAT3 targets genome-wide. Specifically, we have used chromatin immunoprecipitation and massive parallel sequencing to comprehensively enumerate STAT3 target genes in Th17 cells. We found that STAT3 bound to multiple genes involved in Th17 cell differentiation, cell activation, proliferation, and survival, regulating both expression and epigenetic modifications. Thus, STAT3 orchestrates multiple critical aspects of T cell function in inflammation and homeostasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MAP3K8 in immunoregluation, host defense and autoimmunity
-
批准号:7964945
-
项目类别:
-
资助金额:$26.71万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Targeting Jak3 in the treatment of autoimmune disease
-
批准号:7964897
-
项目类别:
-
资助金额:$26.71万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Cytokine Signaling and Primary Immunodeficiency
-
批准号:8746512
-
项目类别:
-
资助金额:$16.68万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Targeting Jak3 in the treatment of autoimmune disease
-
批准号:8939413
-
项目类别:
-
资助金额:$37.59万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
MAP3K8 in immunoregluation, host defense and autoimmunity
-
批准号:8157152
-
项目类别:
-
资助金额:$26.81万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Stat transcription factors in immunoregulation and autoimmune disease
-
批准号:8157151
-
项目类别:
-
资助金额:$184.96万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
NCRM Director Recruitment, Staff Hires, and IRP Training
-
批准号:8158318
-
项目类别:
-
资助金额:$40.01万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Targeting Janus kinases in the treatment of autoimmune disease
-
批准号:9360989
-
项目类别:
-
资助金额:$27.48万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Targeting Janus kinases in the treatment of autoimmune disease
-
批准号:10712572
-
项目类别:
-
资助金额:$24.48万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Stat transcription factors in immunoregulation and autoimmune disease
-
批准号:9360990
-
项目类别:
-
资助金额:$233.57万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Cytokine Signaling and Primary Immunodeficiency
-
批准号:10019961
-
项目类别:
-
资助金额:$24.3万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Targeting Janus kinases in the treatment of autoimmune disease
-
批准号:10265198
-
项目类别:
-
资助金额:$35.45万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Cytokine signaling, immunoregulation and autoimmune disease
-
批准号:10271324
-
项目类别:
-
资助金额:$319.04万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Stat transcription factors in immunoregulation and autoimmune disease
-
批准号:8939426
-
项目类别:
-
资助金额:$319.54万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Stat transcription factors in immunoregulation and autoimmune disease
-
批准号:9155471
-
项目类别:
-
资助金额:$275.7万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Cytokine signaling, immunoregulation and autoimmune disease
-
批准号:10712574
-
项目类别:
-
资助金额:$220.34万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Mechanisms of gene expression and recombination
-
批准号:10928536
-
项目类别:
-
资助金额:$135.08万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Targeting Jak3 in the treatment of autoimmune disease
-
批准号:8157134
-
项目类别:
-
资助金额:$26.81万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Targeting Jak3 in the treatment of autoimmune disease
-
批准号:8746493
-
项目类别:
-
资助金额:$6.67万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Stat transcription factors in immunoregulation and autoimmune disease
-
批准号:8746508
-
项目类别:
-
资助金额:$310.29万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位: